Prestige Consumer Healthcare Inc. (NYSE:PBH) Stake Boosted by Bank of America Corp DE

Bank of America Corp DE raised its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 594,098 shares of the company's stock after purchasing an additional 35,830 shares during the quarter. Bank of America Corp DE owned 1.20% of Prestige Consumer Healthcare worth $46,393,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Barclays PLC raised its holdings in shares of Prestige Consumer Healthcare by 346.3% in the 3rd quarter. Barclays PLC now owns 92,444 shares of the company's stock valued at $6,665,000 after buying an additional 71,730 shares during the period. Franklin Resources Inc. raised its holdings in shares of Prestige Consumer Healthcare by 4.3% in the 3rd quarter. Franklin Resources Inc. now owns 21,585 shares of the company's stock valued at $1,513,000 after buying an additional 894 shares during the period. Assenagon Asset Management S.A. grew its stake in Prestige Consumer Healthcare by 171.6% during the 4th quarter. Assenagon Asset Management S.A. now owns 46,931 shares of the company's stock worth $3,665,000 after purchasing an additional 29,649 shares in the last quarter. Diversify Wealth Management LLC grew its stake in Prestige Consumer Healthcare by 35.3% during the 4th quarter. Diversify Wealth Management LLC now owns 10,399 shares of the company's stock worth $770,000 after purchasing an additional 2,713 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in Prestige Consumer Healthcare by 18.8% during the 4th quarter. SG Americas Securities LLC now owns 5,996 shares of the company's stock worth $468,000 after purchasing an additional 947 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on PBH. Canaccord Genuity Group boosted their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. StockNews.com raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday. Oppenheimer upped their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research note on Thursday, February 13th. Royal Bank of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Finally, DA Davidson increased their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $93.33.

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares of the company's stock, valued at $1,544,130. The trade was a 8.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock traded down $0.01 during mid-day trading on Tuesday, hitting $88.94. 39,375 shares of the company were exchanged, compared to its average volume of 293,960. The company has a market capitalization of $4.39 billion, a P/E ratio of 20.83, a PEG ratio of 2.69 and a beta of 0.44. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The business's 50 day simple moving average is $83.37 and its two-hundred day simple moving average is $82.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. The firm had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.02 earnings per share. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.